Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1), approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others previously showed that HIV-1 viral RNAs, such as trans-activating response (TAR) RNA, are incorporated into extracellular...
Main Authors: | Catherine DeMarino, Maria Cowen, Pooja Khatkar, Bianca Cotto, Heather Branscome, Yuriy Kim, Sarah Al Sharif, Emmanuel T. Agbottah, Weidong Zhou, Cecilia T. Costiniuk, Mohammad-Ali Jenabian, Cohava Gelber, Lance A. Liotta, Dianne Langford, Fatah Kashanchi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/4/723 |
Similar Items
-
The Use of CBD and Its Synthetic Analog HU308 in HIV-1-Infected Myeloid Cells
by: Anastasia Williams, et al.
Published: (2023-08-01) -
Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger
by: Sarah Al Sharif, et al.
Published: (2020-12-01) -
Cannabinoids and Chronic Liver Diseases
by: Ralph-Sydney Mboumba Bouassa, et al.
Published: (2022-08-01) -
Marijuana and the cannabinoids /
by: ElSohly, Mahmoud A.
Published: (2007) -
The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects
by: R. G. Akzhigitov, et al.
Published: (2020-08-01)